These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11686041

  • 1. Purification of plasmids for gene therapy and DNA vaccination.
    Prazeres DM, Monteiro GA, Ferreira GN, Diogo MM, Ribeiro SC, Cabral JM.
    Biotechnol Annu Rev; 2001; 7():1-30. PubMed ID: 11686041
    [Abstract] [Full Text] [Related]

  • 2. Plasmid DNA for pharmaceutical applications.
    Schleef M, Schmidt T, Flaschel E.
    Dev Biol (Basel); 2000; 104():25-31. PubMed ID: 11713820
    [Abstract] [Full Text] [Related]

  • 3. Plasmid DNA of high quality purified by activated charcoal.
    Kim JY, Cho C, Cho BN.
    J Biosci Bioeng; 2010 Nov; 110(5):608-13. PubMed ID: 20638332
    [Abstract] [Full Text] [Related]

  • 4. Plasmid DNA for clinical phase I and II studies. Large-scale cGMP manufacturing and quality assurance.
    Schleef M, Schorr J.
    Adv Exp Med Biol; 1998 Nov; 451():481-6. PubMed ID: 10026915
    [No Abstract] [Full Text] [Related]

  • 5. A simple method for the production of plasmid DNA in bioreactors.
    Listner K, Bentley LK, Chartrain M.
    Methods Mol Med; 2006 Nov; 127():295-309. PubMed ID: 16988462
    [Abstract] [Full Text] [Related]

  • 6. Plasmid DNA production for therapeutic applications.
    Lara AR, Ramírez OT, Wunderlich M.
    Methods Mol Biol; 2012 Nov; 824():271-303. PubMed ID: 22160904
    [Abstract] [Full Text] [Related]

  • 7. Production and purification of plasmid DNA vaccines: is there scope for further innovation?
    Xenopoulos A, Pattnaik P.
    Expert Rev Vaccines; 2014 Dec; 13(12):1537-51. PubMed ID: 25308708
    [Abstract] [Full Text] [Related]

  • 8. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications.
    Ferreira GN, Monteiro GA, Prazeres DM, Cabral JM.
    Trends Biotechnol; 2000 Sep; 18(9):380-8. PubMed ID: 10942962
    [Abstract] [Full Text] [Related]

  • 9. Plasmid fermentation process for DNA immunization applications.
    Carnes AE, Williams JA.
    Methods Mol Biol; 2014 Sep; 1143():197-217. PubMed ID: 24715290
    [Abstract] [Full Text] [Related]

  • 10. Marker-free plasmids for biotechnological applications - implications and perspectives.
    Oliveira PH, Mairhofer J.
    Trends Biotechnol; 2013 Sep; 31(9):539-47. PubMed ID: 23830144
    [Abstract] [Full Text] [Related]

  • 11. Optimizing a Method for the Quantification by Quantitative Real-Time Polymerase Chain Reaction of Host Cell DNA in Plasmid Vector Batches Used in Human Gene Therapy.
    Ferro S, Fabre I, Chenivesse X.
    Hum Gene Ther Methods; 2016 Aug; 27(4):159-70. PubMed ID: 27440556
    [Abstract] [Full Text] [Related]

  • 12. Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.
    Williams JA, Luke J, Langtry S, Anderson S, Hodgson CP, Carnes AE.
    Biotechnol Bioeng; 2009 Aug 15; 103(6):1129-43. PubMed ID: 19408315
    [Abstract] [Full Text] [Related]

  • 13. Assessment of UV spectrophotometry for determination of plasmid DNA concentration in vector preparations for human gene therapy products.
    Chenivesse X, Anliker B, Daas A, Ferro S, Meier R, Renner M, Costanzo A.
    Pharmeur Bio Sci Notes; 2017 Aug 15; 2017():88-112. PubMed ID: 29191266
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM, Prather KL.
    Appl Microbiol Biotechnol; 2009 Apr 15; 82(5):805-13. PubMed ID: 19205691
    [Abstract] [Full Text] [Related]

  • 16. Main Features of DNA-Based Vectors for Use in Lactic Acid Bacteria and Update Protocols.
    Coelho-Rocha ND, Barroso FAL, Tavares LM, Dos Santos ESS, Azevedo V, Drumond MM, Mancha-Agresti P.
    Methods Mol Biol; 2021 Apr 15; 2197():285-304. PubMed ID: 32827144
    [Abstract] [Full Text] [Related]

  • 17. Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications.
    Sousa A, Tomaz CT, Sousa F, Queiroz JA.
    J Chromatogr A; 2011 Nov 18; 1218(46):8333-43. PubMed ID: 21995857
    [Abstract] [Full Text] [Related]

  • 18. Design of plasmid DNA constructs for vaccines.
    Montgomery DL, Prather KJ.
    Methods Mol Med; 2006 Nov 18; 127():11-22. PubMed ID: 16988443
    [Abstract] [Full Text] [Related]

  • 19. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA, Meek JA, Budahazi G, Marquet M.
    Hum Gene Ther; 1995 May 18; 6(5):565-73. PubMed ID: 7578394
    [Abstract] [Full Text] [Related]

  • 20. Advances in host and vector development for the production of plasmid DNA vaccines.
    Mairhofer J, Lara AR.
    Methods Mol Biol; 2014 May 18; 1139():505-41. PubMed ID: 24619702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.